Europe

R&D

Biosimilars - clinically equivalent alternatives to original biologic drugs - play a vital role in addressing unmet health needs.

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

R&D

It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.

News

Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX

Digital

Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster

Digital

Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys